ArticleMolecular pharmacology2022

A Recombinant Dimethylarginine Dimethylaminohydrolase-1-Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity.

Young Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.